Bio-Techne Corporation
TECH
$54.41
$1.492.82%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.55% | 4.20% | 8.96% | 4.52% | 1.59% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.55% | 4.20% | 8.96% | 4.52% | 1.59% |
| Cost of Revenue | 4.72% | 3.15% | 5.93% | 10.69% | 4.58% |
| Gross Profit | 2.97% | 4.71% | 10.58% | 1.47% | 0.17% |
| SG&A Expenses | -38.87% | 38.75% | 12.32% | 4.02% | 11.45% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.53% | 17.37% | 9.29% | 6.27% | 4.76% |
| Operating Income | 47.75% | -38.10% | 7.48% | -2.69% | -6.71% |
| Income Before Tax | -154.87% | -37.34% | 28.42% | -18.94% | -52.83% |
| Income Tax Expenses | -582.85% | 30.44% | 34.85% | 557.91% | -91.64% |
| Earnings from Continuing Operations | -143.55% | -53.96% | 27.03% | -34.11% | -46.23% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -143.55% | -53.96% | 27.03% | -34.11% | -46.23% |
| EBIT | 47.75% | -38.10% | 7.48% | -2.69% | -6.71% |
| EBITDA | 34.21% | -27.36% | 3.84% | -2.25% | -4.04% |
| EPS Basic | -144.47% | -53.98% | 26.33% | -34.27% | -46.36% |
| Normalized Basic EPS | 61.01% | -33.17% | 7.82% | 10.95% | -6.43% |
| EPS Diluted | -145.25% | -54.84% | 29.41% | -32.26% | -44.19% |
| Normalized Diluted EPS | 62.97% | -32.52% | 8.06% | 11.81% | -5.49% |
| Average Basic Shares Outstanding | -1.87% | 0.04% | 0.57% | 0.25% | 0.23% |
| Average Diluted Shares Outstanding | -3.05% | -0.97% | 0.35% | -0.51% | -0.78% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -3.25% | 1.17% | -0.20% | 0.52% | 0.86% |